Researchers at Johns Hopkins Medicine say they have successfully demonstrated that disrupting an eye structure long suspected ...
Special Protocol Assessment (SPA) agreement with the U.S. FDA provides regulatory alignment on the registrational path for Privosegtor in optic ...
Glaucoma is often called the “silent thief of sight” for one reason: most people do not realize they have it until permanent ...
Degeneration of retinal ganglion cells can cause irreversible vision loss. Pluripotent stem cells (PSCs) could, in theory, be ...
Traumatic injury to the brain, spinal cord and optic nerve in the central nervous system (CNS) are the leading cause of disability and the second leading cause of death worldwide. CNS injuries often ...
Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer, ...
InvestorsHub on MSN
Meet the micro-cap biotech company reinventing regenerative medicine
But the body’s regenerative powers are not evenly distributed. Skin, blood and certain tissues can repair themselves ...
Many people experience vision problems in MS. Learn about common eye symptoms, including eye pain, blurry vision, and double vision.
An optic nerve glioma is a type of noncancerous, slow-growing tumor that develops in the glial cells of the optic nerve. They are most common in children. Doctors may refer to this type of tumor as ...
An 80-year-old man was referred for gradual worsening vision loss in his right eye.Specifically, he noted having to actively ...
Oculis announces agreement with US FDA on a Special Protocol Assessment for optic neuritis registrational trial: Zug, Switzerland Saturday, May 9, 2026, 11:00 Hrs [IST] Oculis Hol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results